Fukuda N, Toda K, Ohmoto A, Wang X, et al. Baseline Tumour Size as a Prognostic Factor for Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib. Anticancer Res 2021;41:1683-1691.
PMID: 33788766